Your browser does not support JavaScript capabilities, which maybe required to display this page properly.


PDF FormatRequires Adobe Acrobat Reader

Table 12.12

Adjusted Patient Survival, Deceased Donor Lung Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2006 - 2007) (Tx 2006 - 2007) (Tx 2002 - 2007) (Tx 1997 - 2007)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 2,718 92.6% 0.5% 2,718 84.0% 0.7% 7,199 53.5% 0.8% 11,661 27.0% 0.8%
Lung Diagnosis Group Group A: Obstructive Lung Disease 1,048 92.5% 2.6% 1,048 82.5% 5.6% 3,209 43.9% 5.2% 5,698 18.6% 3.0%
Group B: Pulmonary Vascular Disease 91 92.0% 6.9% 91 86.7% 10.9% 281 44.0% 17.9% 519 27.6% 9.7%
Group C: Cystic Fibrosis or Immunodef. Disorders 398 89.5% 10.0% 398 75.6% 21.1% 1,074 56.9% 11.3% 1,778 35.0% 7.9%
Group D: Restrictive Lung Disease 1,123 94.2% 1.7% 1,123 87.6% 3.4% 2,479 61.5% 3.9% 3,364 34.0% 3.5%
Group E: Age Less Than 12 38 75.6% 16.1% 38 64.7% 19.9% 99 64.3% 7.8% 192 44.3% 6.5%
Other Diagnosis 20 95.0% 4.9% 20 95.0% 4.9% 57 69.5% 8.0% 110 28.3% 8.8%


Source: OPTN/SRTR Data as of May 4, 2009.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Patient survival follows patients from first transplant of this type until death. Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on lung and heart-lung transplants.

Multi-organ transplants are excluded.

Survival rates are adjusted to the characteristics of the 3 month and 1 year cohort. See Technical Notes for details.



PDF FormatRequires Adobe Acrobat Reader